<DOC>
	<DOCNO>NCT00126217</DOCNO>
	<brief_summary>BCG mark immune stimulatory effect animal human study observational study suggest BCG associate non-specific reduction mortality area high infant child mortality . The specific objective study examine effect revaccination purify protein derivative tuberculin ( PPD ) reaction , scar size , morbidity mortality randomise prospective study revaccination versus revaccination among child 19 month age Guinea-Bissau . The hypothesis revaccination BCG reduce childhood mortality 19 month age 30 % .</brief_summary>
	<brief_title>Revaccination Young Children With Bacille Calmette Guerin ( BCG ) Vaccine</brief_title>
	<detailed_description>Examine randomise trial whether revaccination BCG reduce childhood mortality 19 month age 30 % . Criteria verification : 3,000 child age 1Â½ year enrol follow average 3 year ; information potential adverse event among child positive PPD reaction ; assessment parasitaemia revaccination ; assessment tuberculin response scar-formation revaccination ; assessment all-cause mortality period follow-up . Following consent participate , child assess BCG scar tuberculin reaction 18-19 month age . Subsequently , child invite clinical examination one health centre . The study explain mother , accepts participate , draw randomisation number decide whether child revaccinated . The BCG vaccine give standard dose 0.1 ml recommend WHO age group . In begin study , group 800 revaccinated revaccinated child follow weekly two month monitor morbidity possible adverse effect vaccination . It expect Koch like reaction common age group . However , many adverse reaction among child positive tuberculin test , tuberculin negative child include continuation trial . Two month inclusion , child another tuberculin test examine change tuberculin reaction . At time , scar-size measure . In initial phase project , finger-prick blood sample collect 1000 child examine whether BCG boosting/no boost effect prevalence malaria parasitaemia level measles antibody . Children malaria treat child non-protective level measles antibody offer revaccination measles vaccine . In group child , sample collect BCG revaccination/no revaccination measure change cytokine profile . Children large PPD reaction ( &gt; 15mm ) follow similar way child may reflect immune stimulation exposure natural TB . The study morbidity immunological change do dry rainy season . The child follow hospitalisation mortality 5 year age .</detailed_description>
	<mesh_term>Malaria</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>No overt illness PPD reaction &gt; 15mm</criteria>
	<gender>All</gender>
	<minimum_age>19 Months</minimum_age>
	<maximum_age>24 Months</maximum_age>
	<verification_date>October 2008</verification_date>
	<keyword>Non-specific effect vaccine</keyword>
	<keyword>Infant mortality</keyword>
	<keyword>Morbidity</keyword>
	<keyword>Low income country</keyword>
	<keyword>Malaria</keyword>
	<keyword>BCG</keyword>
	<keyword>immunisation</keyword>
	<keyword>BCG revaccination</keyword>
	<keyword>Tuberculin</keyword>
	<keyword>Mortality</keyword>
</DOC>